The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial | Zendy

Avraham BenChetrit | Zendy; Talia EldarGeva | Zendy; M. Ga�l | Zendy; Michael Huerta | Zendy; Tzvia Mimon | Zendy; Nurit Algur | Zendy; Yoram Z. Diamant | Zendy; Ehud J. Margalioth | Zendy

Open Access

The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial

Author(s) -

Avraham BenChetrit,

Talia EldarGeva,

M. Ga�l,

Michael Huerta,

Tzvia Mimon,

Nurit Algur,

Yoram Z. Diamant,

Ehud J. Margalioth

Publication year - 2001

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/16.9.1880

Subject(s) - ovarian hyperstimulation syndrome , medicine , relative risk , randomized controlled trial , placebo , nausea , pregnancy rate , pregnancy , incidence (geometry) , vomiting , rate ratio , gynecology , anesthesia , obstetrics , surgery , confidence interval , in vitro fertilisation , genetics , alternative medicine , physics , pathology , optics , biology

The role of intravenous (IV) albumin administration in the prevention of ovarian hyperstimulation syndrome (OHSS) and in the improvement of IVF conception outcomes was evaluated in a prospective, randomized, placebo-controlled double blind study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research